NO981748L - Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette - Google Patents

Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette

Info

Publication number
NO981748L
NO981748L NO981748A NO981748A NO981748L NO 981748 L NO981748 L NO 981748L NO 981748 A NO981748 A NO 981748A NO 981748 A NO981748 A NO 981748A NO 981748 L NO981748 L NO 981748L
Authority
NO
Norway
Prior art keywords
well
new dna
protein
producing protein
producing
Prior art date
Application number
NO981748A
Other languages
English (en)
Norwegian (no)
Other versions
NO981748D0 (no
Inventor
Nobuaki Nakagawa
Hisataka Yasuda
Tomonori Morinaga
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of NO981748D0 publication Critical patent/NO981748D0/no
Publication of NO981748L publication Critical patent/NO981748L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO981748A 1996-08-19 1998-04-17 Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette NO981748L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法
PCT/JP1997/002859 WO1998007840A1 (fr) 1996-08-19 1997-08-19 Nouveaux adn et procede de production de proteines a l'aide de ces derniers

Publications (2)

Publication Number Publication Date
NO981748D0 NO981748D0 (no) 1998-04-17
NO981748L true NO981748L (no) 1998-06-18

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981748A NO981748L (no) 1996-08-19 1998-04-17 Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette

Country Status (12)

Country Link
EP (1) EP0874045A1 (index.php)
JP (1) JPH1057071A (index.php)
KR (1) KR20000064276A (index.php)
CN (1) CN1198776A (index.php)
AU (1) AU718458B2 (index.php)
CA (1) CA2235148A1 (index.php)
FI (1) FI980853A7 (index.php)
HU (1) HUP0001837A3 (index.php)
NO (1) NO981748L (index.php)
NZ (1) NZ330400A (index.php)
WO (1) WO1998007840A1 (index.php)
ZA (1) ZA977402B (index.php)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
ES2144386T5 (es) 1996-12-23 2012-12-07 Immunex Corporation Ligando para el activador del receptor de NF-kappa b, el ligando es miembro de la superfamilia de TNF
WO1999058674A2 (en) 1998-05-14 1999-11-18 Immunex Corporation Method of inhibiting osteoclast activity
IL127115A (en) 1997-04-15 2013-08-29 Daiichi Sankyo Co Ltd A substance for the treatment of diseases related to bone metabolism problem
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
ATE363533T1 (de) 1997-04-16 2007-06-15 Amgen Inc Osteoprotegerin bindende proteine und rezeptoren
HUP0002062A3 (en) 1997-09-24 2002-09-30 Sankyo Co Method for diagnosing bone dysbolism
KR20010082272A (ko) 1998-10-28 2001-08-29 쇼노 카츄야 골대사이상증 치료제
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
WO2001023562A2 (en) * 1999-09-27 2001-04-05 Eli Lilly And Company Osteoprotegerin regulatory region
RU2324705C2 (ru) 2001-04-03 2008-05-20 Сосьете Де Продюи Нестле С.А. Остеопротегерин, применение его для изготовления фармацевтической композиции (варианты) и получения пищевого продукта (варианты) и корма для животных, пищевой продукт, корм для животных и фармацевтическая композиция для профилактики или лечения расстройств, связанных с костным ремоделированием, и/или иммунных расстройств
KR100942393B1 (ko) 2001-05-25 2010-02-17 휴먼 게놈 사이언시즈, 인코포레이티드 Ｔｒａｉｌ 수용체에 면역특이적으로 결합하는 항체
PL375041A1 (en) 2002-04-05 2005-11-14 Amgen Inc. Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
ZA977402B (en) 1999-02-18
FI980853L (fi) 1998-06-15
AU718458B2 (en) 2000-04-13
NZ330400A (en) 1999-05-28
HUP0001837A2 (hu) 2000-09-28
HUP0001837A3 (en) 2002-09-30
EP0874045A4 (index.php) 1998-11-18
NO981748D0 (no) 1998-04-17
CA2235148A1 (en) 1998-02-26
FI980853A7 (fi) 1998-06-15
EP0874045A1 (en) 1998-10-28
JPH1057071A (ja) 1998-03-03
FI980853A0 (fi) 1998-04-17
AU3866197A (en) 1998-05-11
KR20000064276A (ko) 2000-11-06
MX9803086A (es) 1998-11-29
CN1198776A (zh) 1998-11-11
WO1998007840A1 (fr) 1998-02-26

Similar Documents

Publication Publication Date Title
NO981748L (no) Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette
Kreimeyer et al. DNA repair-associated ADP-ribosylation in vivo. Modification of histone H1 differs from that of the principal acceptor proteins.
IL86480A (en) Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
BR0106682A (pt) Molécula de anticorpo, variante de molécula de anticorpo, anticorpo, composto, sequência de dna, vetor de clonagem ou de expressão, vetor de expressão de e. coli, célula hospedeira, processo para a produção da molécula de anticorpo, composição terapêutica ou diagnóstica, uso da molécula de anticorpo, vetorpdnabeng-g1, vetorptto(cdp870), e, polipeptìdeo
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
AU2002339458A1 (en) Sirna knockout assay method and constructs
NO177433C (no) DNA-vektor for ekspresjon av desulfatohirudin i gjær eller E.coli samt fremgangsmåte for fremstilling av desulfatohirudin og salter derav
DK338788A (da) Fremgangsmaade til transformering af celler
DE69840333D1 (de) 2-m übergang des zellzyklus
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
AU3230797A (en) Dna encoding dp. 75 and a process for its use
WO1998011234A3 (en) Human protein kinases
Pettijohn Ordered and preferential initiation of ribosomal RNA synthesis in vitro
BR0317537A (pt) Processo para preparar aminoácidos em organismos transgênicos, construção de ácido nucleico, vetor, organismo procariótico ou eucariótico transgênico, uso dos organismos transgênicos, e, sequencia de aminoácidos
FR2814744B1 (fr) Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
Lanzendörfer et al. Structure and function of the DNA-dependent RNA polymerase of Sulfolobus
AU4302000A (en) Genome sequence and polypeptides of pyrococcus (abissy), fragment and uses thereof
CA2327587A1 (en) Methods for treatment of haemophilia a patients using human anti-human fviii antibodies
Crawford et al. DNA sequence of the tryptophan synthase genes of Pseudomonas putida
WO2000024765A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
Biswas et al. DNA helicase associated with DNA polymerase. alpha.: Isolation by a modified immunoaffinity chromatography
Amblar et al. Purification and properties of the 5′-3′ exonuclease D10A mutant of DNA polymerase I from Streptococcus pneumoniae: a new tool for DNA sequencing
Katouzian-Safadi et al. Identification of the DNA-interacting sites of proteins: Microsequencing of the peptides cross-linked to 5-bromouracil substituted DNA